We treat more than 800 children, teens and young adults each year with cancers and serious blood disorders.

Board-certified pediatric hematologist/oncologists are available 24/7, along with pediatric sub-specialists for consultations. A wide range of diagnostic services and treatments available in our specially designed unit.

There are many types of blood disorders, which can involve problems with bone marrow, blood vessels, lymph nodes, platelet, proteins red blood cells or white blood cells, involved in bleeding and/or clotting. Patients and families receive care from experienced hematologists that treat a wide range of serious blood disorders. 


We provide, multi-disciplinary care and support for children diagnosed with many forms of serious blood disorders. 

Our multi-disciplinary teams meet in conferences to review each child’s progress at every phase of treatment, resulting in individualized treatment recommendations from an experienced and dedicated care team. Our hematologists provide comprehensive diagnostic, treatment and preventative care for a wide range of non-malignant blood disorders in children, teens and young adults. 

In addition to hematologic treatment needs, Jaques Children’s Cancer Institute also is heavily involved in research to help find cures and discover new treatments for serious blood disorders.

Condition Management

The hematology/oncology care team offers multi-specialty medical care, including assessment, consultation, treatment and preventative care. Developmental screening and psychological evaluation are tools the hematology/oncology team uses to ensure the condition and treatment plan is being managed appropriately. Your child’s hematologist/oncologist acts as a consult for any patient that is hospitalized with a pediatric hematology/oncology condition.   


Hemophilia Program offers a multi-disciplinary care team that works with patients and families to learn about hemophilia and important preventative bleeding care. Together, we address all issues related to hemophilia. We provide health education that help patients stay healthy.

Hemophilia is a rare genetic (inherited) disorder. Children with hemophilia have blood that in unable to clot properly. This happens because the body does not have sufficient blood-clotting proteins (clotting factors), making it hard for bleeding to stop. Children with hemophilia may bleed for a longer time after an injuries, like cuts, during surgery and even after bad falls.

Treatment for hemophilia includes regular replacement of the specific clotting factor that is reduced. 

Children with hemophilia can live full lives and enjoy most of the same activities that other people do. If your child has hemophilia education is key to keeping them as healthy as possible.

In addition to hemophilia treatment needs, Jaques Children’s Cancer Institute also is heavily involved in research to help find cures and discover new treatments for serious blood disorders.

Hemophilia Care & Bleeding Prevention 

Several different types of clotting factors are associated with different varieties of hemophilia. The main treatment for severe hemophilia involves receiving replacement of the specific clotting factor that you need, through a tube placed in a vein.

This replacement therapy can be given to combat a bleeding episode that's in progress. It can also be administered on a regular schedule at home to help prevent bleeding episodes. Some people receive continuous replacement therapy.

Replacement clotting factor can be made from donated blood. Similar products, called recombinant clotting factors, aren't made from human blood.

Often, patients and families can learn how to perform infusions themselves to that they can stop bleeding episodes and even perform infusions on a regular basis so that they can prevent most bleeding episodes.

We participate in a national hemophilia registry (HTRS) to gain a better understanding of the hemophilia disease and monitor and track treatments that work or could be improved on a national level.

Patients with hemophilia receive at least one annual comprehensive assessment by the hemophilia care team to ensure that treatment and condition management plans are on track.

Centers & Programs